Hang Seng Medical ETF (513060) fluctuated and flushed, Tengsheng Bo medicine-B rose by more than 14%

In the afternoon, Hang Seng Medical ETF (513060) fluctuated and flooded, up exceeding 0.5%. Among the ingredients stocks, the pharmaceutical sector strengthened, Tengsheng Bo Pharmaceutical -B rose by over 14%, clover biological-B rose more than 5%, Stone Medicine Group and Fosun Pharmaceuticals rose more than 4%. Retoning more than 3%, federal pharmaceuticals, Nuohui Health-B, and Huang Medicine have risen. As of press time, the turnover of Hang Seng Medical ETF (513060) exceeded 1.1 billion, and the turnover rate exceeded 17%.

On the news, my country's prevention and control measures continue to improve: clearing the zero dynamic and clearing zero science precision+dynamic clearance; at the end of June, the time of secret and entry personnel isolation and control to "7+3", the itinerary card cancels the "star number" mark. The new crown medicine is an indispensable part of the epidemic prevention and control. A variety of domestic new crown special drugs have entered the clinical stage and are expected to be approved within the year.

Wanhe Securities said that the valuation of the pharmaceutical industry has bottomed out, and the performance of the fields of epidemic and bases is expected to accelerate repair. As an industry with both rigidity, consumption type and growth, medicine is based on the current sector's valuation at a relatively low level. With the policy intensive assistance and the development of domestic new crown drugs, the industry recovery is available.

- END -